Table 2 Expected adverse events

   ∘ Hypotension during dialysis

   ∘ Infections and infestations

   ∘ Dialysis line exit site infection

   ∘ Neoplasms benign, malignant and unspecified

   ∘ Cardiac arrhythmia

   ∘ Blood and lymphatic system disorders

   ∘ Septicaemia

   ∘ Immune system disorders

   ∘ Endocarditis

   ∘ Endocrine disorders

   ∘ Fluid overload

   ∘ Metabolism and nutrition disorders

   ∘ Peripheral oedema

   ∘ Psychiatric disorders

   ∘ Hypoalbuminemia

   ∘ Nervous system disorders

   ∘ Hypophosphatemia, hypomagnesemia, hypokalaemia, hypocalcaemia

   ∘ Eye disorders

   ∘ Hypersensitivity reactions

   ∘ Ear and labyrinth disorders

   ∘ Cardiac disorders (including cardiac tamponade)

   ∘ Vascular disorders

   ∘ Respiratory, thoracic and mediastinal disorders (including Pneumonitis, interstitial pneumonia, Acute Respiratory Distress Syndrome)

   ∘ Gastrointestinal disorders (including ischemic colitis and liver failure, hepatobiliary disorders)

   ∘ Skin and subcutaneous tissue disorders

   ∘ Musculoskeletal and connective tissue disorders

   ∘ Renal and urinary disorders

   ∘ Reproductive system and breast disorders

   ∘ Herpes meningoencephalitis

   ∘ Angioedema

   ∘ Encephalopathy, autonomic neuropathy

   ∘ Ophthalmic herpes